Winch Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 528 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 521 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 516 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 556 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 569 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 488 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 469 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 455 |
|
|
2023
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 439 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 462 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 455 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 450 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 441 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 447 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 495 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 496 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 511 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 524 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 477 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 467 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 421 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 406 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 391 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 382 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 443 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 479 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 404 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 374 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 357 |
|
|
2018
Q2 | $0 | Sell |
1
-5
| -83% | -$1.34K | ﹤0.01% | 370 |
|
|
2018
Q1 | $1K | Sell |
6
-1
| -14% | -$262 | ﹤0.01% | 300 |
|
|
2017
Q4 | $2K | Sell |
7
-29
| -81% | -$9.54K | ﹤0.01% | 272 |
|
|
2017
Q3 | $13K | Buy |
36
+22
| +157% | +$7.81K | 0.01% | 155 |
|
|
2017
Q2 | $5K | Buy |
+14
| New | +$4.19K | ﹤0.01% | 223 |
|
Winch Advisory Services's DMK Position: Q1 2026 in Review
Winch Advisory Services held its DMK Pharmaceuticals Corporation Common Stock (DMK) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #528.
Winch Advisory Services first reported a position in DMK in Q2 2017 and has held it in 36 quarters since. The position peaked at $13K in Q3 2017. 1 fund tracked by Wall St. Rank holds DMK as of Q1 2026.
- Winch Advisory Services held 1 share of DMK Pharmaceuticals Corporation Common Stock worth $0 as of Q1 2026.
- Winch Advisory Services left its DMK Pharmaceuticals Corporation Common Stock share count unchanged in Q1 2026.
- DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of Winch Advisory Services's portfolio in Q1 2026, its #528 holding.
- Winch Advisory Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and has held it in 36 quarters since.
- Winch Advisory Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $13K in Q3 2017.
- 1 fund tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2026.
Based on Winch Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.